Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling

Experimental Cell Research

Volumn 290, Issue 2, 2003, Pages 370-380

  Shindo, Kentaro ^a   Kawashima, Nobuyuki ^a   Sakamoto, Kei ^a   Yamaguchi, Akira ^b   Umezawa, Akihiro ^c   Takagi, Minoru ^a   Katsube, Ken Ichi ^a   Suda, Hideaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Kusa; Mesenchymal progenitor cells; Mineralization; Notch; Osteogenesis; RANKL

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; NOTCH RECEPTOR; OSTEOCALCIN; TRANSCRIPTION FACTOR;

ABDOMEN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BONE DEVELOPMENT; CALCIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MESENCHYME CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TRABECULAR BONE;

EID: 0142026227     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00349-5     Document Type: Article

References (46)

1. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells nature, biology, and potential applications . Stem Cells. 19:2001;180-192.
2. Van Damme A., Vanden Driessche T., Collen D., Chuah M.K. Bone marrow stromal cells as targets for gene therapy. Curr. Gene Ther. 2:2002;195-209.
3. Rodan G.A., Harada S. The missing bone. Cell. 89:1997;677-680.
4. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21:2000;393-411.
5. Jan Y.N., Jan L.Y. HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell. 75:1993;827-830.
6. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling cell fate control and signal integration in development . Science. 284:1999;770-776.
7. Tax F.E., Yeargers J.J., Thomas J.H. Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. Nature. 368:1994;150-154.
8. Mumm J.S., Schroeter E.H., Saxena M.T., Griesemer A., Tian X., Pan D.J., Ray W.J., Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell. 5:2000;197-206.
9. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., Israel A. Signalling downstream of activated mammalian Notch. Nature. 377:1995;355-358.
10. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 393:1998;382-386.
11. Sternberg P.W. Lateral inhibition during vulval induction in Caenorhabditis elegans. Nature. 335:1988;551-554.
12. Wakamatsu Y., Maynard T.M., Weston J.A. Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis. Development. 127:2000;2811-2821.
13. Kopan R., Nye J.S., Weintraub H. The intracellular domain of mouse Notch a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD . Development. 120:1994;2385-2396.
14. Milner L.A., Bigas A., Kopan R., Brashem-Stein C., Bernstein I.D., Martin D.I. Inhibition of granulocytic differentiation by mNotch1. Proc. Natl. Acad. Sci. USA. 93:1996;13014-13019.
15. Chitnis A., Henrique D., Lewis J., Ish-Horowicz D., Kintner C. Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene Delta. Nature. 375:1995;761-766.
16. Kato H., Taniguchi Y., Kurooka H., Minoguchi S., Sakai T., Nomura-Okazaki S., Tamura K., Honjo T. Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development. 124:1997;4133-4141.
17. Kopan R., Schroeter E.H., Weintraub H., Nye J.S. Signal transduction by activated mNotch importance of proteolytic processing and its regulation by the extracellular domain . Proceedings of the National Academy of Sciences of the United States of America. 93:1996;1683-1688.
18. Hirsinger E., Malapert P., Dubrulle J., Delfini M.C., Duprez D., Henrique D., Ish-Horowicz D., Pourquie O. Notch signalling acts in postmitotic avian myogenic cells to control MyoD activation. Development. 128:2001;107-116.
19. Penta K., Varner J.A., Liaw L., Hidai C., Schatzman R., Quertermous T. Dell induces integrin signaling and angiogenesis by ligation of alpha Vbeta3. J. Biol. Chem. 274:1999;11101-11109.
20. Crowe R., Zikherman J., Niswander L. Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation. Development. 126:1999;987-998.
21. Dallas D.J., Genever P.G., Patton A.J., Millichip M.I., McKie N., Skerry T.M. Localization of ADAM10 and Notch receptors in bone. Bone. 25:1999;9-15.
22. Schnabel M., Fichtel I., Gotzen L., Schlegel J. Differential expression of Notch genes in human osteoblastic cells. Int J. Mol. Med. 9:2002;229-232.
23. Umezawa A., Maruyama T., Segawa K., Shadduck R.K., Waheed A., Hata J. Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J. Cell. Physiol. 151:1992;197-205.
24. Kohyama J., Abe H., Shimazaki T., Koizumi A., Nakashima K., Gojo S., Taga T., Okano H., Hata J., Umezawa A. Brain from bone efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent . Differentiation. 68:2001;235-244.
25. Ochi K., Chen G., Ushida T., Gojo S., Segawa K., Tai H., Ueno K., Ohkawa H., Mori T., Yamaguchi A., Toyama Y., Hata J., Umezawa A. Use of isolated mature osteoblasts in abundance acts as desired-shaped bone regeneration in combination with a modified poly-DL-lactic-co-glycolic acid (PLGA)-collagen sponge. J. Cell. Physiol. 194:2003;45-53.
26. Sakamoto K., Ohara O., Takagi M., Takeda S., Katsube K. Intracellular cell-autonomous association of Notch and its ligands a novel mechanism of Notch signal modification . Dev. Biol. 241:2002;313-326.
27. Mukohyama H., Ransjo M., Taniguchi H., Ohyama T., Lerner U.H. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. Biochem. Biophys. Res. Commun. 271:2000;158-163.
28. Fujiwara M., Tagashira S., Harada H., Ogawa S., Katsumata T., Nakatsuka M., Komori T., Takada H. Isolation and characterization of the distal promoter region of mouse Cbfa1. Biochim. Biophys. Acta. 1446:1999;265-272.
29. Kern B., Shen J., Starbuck M., Karsenty G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 276:2001;7101-7107.
30. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell Biol. 15:1995;1858-1869.
31. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1 a transcriptional activator of osteoblast differentiation . Cell. 89:1997;747-754.
32. Stein G.S., Lian J.B., Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. Faseb J. 4:1990;3111-3123.
33. Siggelkow H., Rebenstorff K., Kurre W., Niedhart C., Engel I., Schulz H., Atkinson M.J., Hufner M. Development of the osteoblast phenotype in primary human osteoblasts in culture comparison with rat calvarial cells in osteoblast differentiation . J. Cell. Biochem. 75:1999;22-35.
34. Doty S.B., Schofield B.H. Enzyme histochemistry of bone and cartilage cells. Prog. Histochem. Cytochem. 8:1976;1-38.
35. Beck G.R. Jr., Sullivan E.C., Moran E., Zerler B. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J. Cell. Biochem. 68:1998;269-280.
36. Hitoshi S., Alexson T., Tropepe V., Donoviel D., Elia A.J., Nye J.S., Conlon R.A., Mak T.W., Bernstein A., van der Kooy D. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16:2002;846-858.
37. Varnum-Finney B., Xu L., Brashem-Stein C., Nourigat C., Flowers D., Bakkour S., Pear W.S., Bernstein I.D. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:2000;1278-1281.
38. McLarren K.W., Lo R., Grbavec D., Thirunavukkarasu K., Karsenty G., Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. J. Biol. Chem. 275:2000;530-538.
39. Tezuka K., Yasuda M., Watanabe N., Morimura N., Kuroda K., Miyatani S., Hozumi N. Stimulation of osteoblastic cell differentiation by Notch. J. Bone Miner. Res. 17:2002;231-239.
40. Kurokawa M., Tanaka T., Tanaka K., Hirano N., Ogawa S., Mitani K., Yazaki Y., Hirai H. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts. J. Biol. Chem. 271:1996;16870-16876.
41. Nofziger D., Miyamoto A., Lyons K.M., Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development. 126:1999;1689-1702.
42. Takahashi N., Udagawa N., Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:1999;449-455.
43. Neale S.D., Smith R., Wass J.A., Athanasou N.A. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone. 27:2000;409-416.
44. Myers D.E., Collier F.M., Minkin C., Wang H., Holloway W.R., Malakellis M., Nicholson G.C. Expression of functional RANK on mature rat and human osteoclasts. FEBS Lett. 463:1999;295-300.
45. Kitazawa R., Kitazawa S., Maeda S. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim. Biophys. Acta. 1445:1999;134-141.
46. O'Brien C.A., Kern B., Gubrij I., Karsenty G., Manolagas S.C. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone. 30:2002;453-462.